Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

504 questions in 57 reviews · Kidney and Transplant

current versions
No studies 504 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Isothermal dialysate vs thermoneutral dialysate
Stroke · patients requiring haemodialysis
Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease… (2019) · Cochrane
no estimate extractedNRNo studies
Fixed reduction of dialysate temperature vs standard dialysate temperature
Death (all causes) · patients requiring haemodialysis
Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease… (2019) · Cochrane
no estimate extractedNRNo studies
Fixed reduction of dialysate temperature vs standard dialysate temperature
Acute coronary syndrome · patients requiring haemodialysis
Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease… (2019) · Cochrane
no estimate extractedNRNo studies
Fixed reduction of dialysate temperature vs standard dialysate temperature
Stroke · patients requiring haemodialysis
Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease… (2019) · Cochrane
no estimate extractedNRNo studies
Summary of findings: exercise vs control
Quality of life · people with CKD
Interventions for improving sleep quality in people with chronic kidney disease (2019) · Cochrane
no estimate extractedNRNo studies
Summary of findings: exercise vs control
Anxiety Beck Anxiety Inventory (BECK) (median · people with CKD
Interventions for improving sleep quality in people with chronic kidney disease (2019) · Cochrane
no estimate extractedNRNo studies
Summary of findings: exercise vs control
Hospitalisation · people with CKD
Interventions for improving sleep quality in people with chronic kidney disease (2019) · Cochrane
no estimate extractedNRNo studies
Summary of findings: acupressure vs control
Quality of life · people with CKD
Interventions for improving sleep quality in people with chronic kidney disease (2019) · Cochrane
no estimate extractedNRNo studies
Summary of findings: acupressure vs control
Anxiety · people with CKD
Interventions for improving sleep quality in people with chronic kidney disease (2019) · Cochrane
no estimate extractedNRNo studies
Summary of findings: relaxation vs control
Sleep latency PSQI (median · people with CKD
Interventions for improving sleep quality in people with chronic kidney disease (2019) · Cochrane
no estimate extractedNRNo studies
Summary of findings: acupressure vs control
Hospitalisation · people with CKD
Interventions for improving sleep quality in people with chronic kidney disease (2019) · Cochrane
no estimate extractedNRNo studies
Summary of findings: relaxation vs control
Hospitalisation (median · people with CKD
Interventions for improving sleep quality in people with chronic kidney disease (2019) · Cochrane
no estimate extractedNRNo studies
Summary of findings: exercise vs control
Sleep latency · people with CKD
Interventions for improving sleep quality in people with chronic kidney disease (2019) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Lanthanum vs placebo/usual care
Cardiovascular death · people with CKD
Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD) (2018) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Iron vs placebo/usual care
Cardiovascular death · people with CKD
Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD) (2018) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Iron vs placebo/usual care
Hypercalcaemia · people with CKD
Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD) (2018) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Sevelamer vs placebo/usual care
Cardiovascular death · people with CKD
Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD) (2018) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Iron vs placebo/usual care
Vomiting · people with CKD
Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD) (2018) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Iron vs placebo/usual care
Coronary artery calcification score · people with CKD
Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD) (2018) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Calcium vs placebo/usual care
Cardiovascular death · people with CKD
Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD) (2018) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Calcium vs placebo/usual care
Vomiting · people with CKD
Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD) (2018) · Cochrane
no estimate extractedNRNo studies
Summary of findings ‐ Lanthanum vs calcium
Cardiovascular death · patients with CKD
Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD) (2018) · Cochrane
no estimate extractedNRNo studies
Omega‐3 fatty acids vs placebo
Serious adverse events: cardiovascular events · Dialysis vascular access outcomes in AVF patients with ESKD
Omega‐3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease (2018) · Cochrane
no estimate extractedNRNo studies
Omega‐3 fatty acids vs placebo
Serious adverse events: major bleeding · Dialysis vascular access outcomes in AVF patients with ESKD
Omega‐3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease (2018) · Cochrane
no estimate extractedNRNo studies
Antibiotics vs no treatment
Outcomes ( · adult kidney transplant recipients
Antibiotics for asymptomatic bacteriuria in kidney transplant recipients (2018) · Cochrane
no estimate extractedNRNo studies
GLP‐1 agonists vs placebo
All cardiovascular death · people with diabetes and CKD
Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease (2018) · Cochrane
no estimate extractedNRNo studies
Glitazone vs placebo
All cardiovascular death · people with diabetes and CKD
Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease (2018) · Cochrane
no estimate extractedNRNo studies
Glitazone vs placebo
eGFR (mL/min/1.73 m2) · people with diabetes and CKD
Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease (2018) · Cochrane
no estimate extractedNRNo studies
Sitagliptin vs glipizide
All cardiovascular death · people with diabetes and CKD
Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease (2018) · Cochrane
no estimate extractedNRNo studies
Intervention NR
All‐cause mortality · CKD patients (any stage) treated for anaemia
Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease (2017) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Hypertension · CKD patients (any stage) treated for anaemia
Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease (2017) · Cochrane
no estimate extractedNRNo studies
Dietary modifications (counselling or dietary change) vs control
Major cardiovascular event · people with CKD
Dietary interventions for adults with chronic kidney disease (2017) · Cochrane
no estimate extractedNRNo studies
Manual acupressure vs routine care
Pain1 Not measured · patients with end‐stage kidney disease
Acupuncture and related interventions for symptoms of chronic kidney disease (2016) · Cochrane
no estimate extractedNRNo studies
Very low vs low protein diet
Mortality · people with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Very low vs low protein diet
Cardiovascular events · people with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Very low vs low protein diet
Fracture · people with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Low phosphorus vs normal diet
Mortality · people with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Low phosphorus vs normal diet
Cardiovascular events · people with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Low phosphorus vs normal diet
Fracture · people with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Post‐haemodialysis dietary supplement vs normal diet
Mortality · people with CKD‐MBD undergoing haemodialysis
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Post‐haemodialysis dietary supplement vs normal diet
Cardiovascular events · people with CKD‐MBD undergoing haemodialysis
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Post‐haemodialysis dietary supplement vs normal diet
Fracture · people with CKD‐MBD undergoing haemodialysis
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Low phosphorus intake (avoiding food additives) vs normal diet
Cardiovascular events · patients with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Low phosphorus intake (avoiding food additives) vs normal diet
Fracture · patients with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Low phosphorus intake plus placebo vs ad libitum diet plus placebo
Mortality · patients with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Low phosphorus intake plus placebo vs ad libitum diet plus placebo
Cardiovascular events · patients with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Low phosphorus intake plus placebo vs ad libitum diet plus placebo
Fracture · patients with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Low phosphorus intake plus lanthanum carbonate vs ad libitum diet plus lanthanum carbonate
Mortality · patients with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Low phosphorus intake plus lanthanum carbonate vs ad libitum diet plus lanthanum carbonate
Cardiovascular events · patients with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies
Low phosphorus intake plus lanthanum carbonate vs ad libitum diet plus lanthanum carbonate
Fracture · patients with CKD‐MBD
Dietary interventions for mineral and bone disorder in people with chronic kidney disease (2015) · Cochrane
no estimate extractedNRNo studies